- Home
- HDL vs OPK Comparison
HDL vs OPK Comparison
Compare HDL & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HDL
- OPK
- Stock Information
- Founded
- HDL 2016
- OPK 2007
- Country
- HDL Singapore
- OPK United States
- Employees
- HDL N/A
- OPK N/A
- Industry
- HDL Restaurants
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- HDL Consumer Discretionary
- OPK Health Care
- Exchange
- HDL Nasdaq
- OPK Nasdaq
- Market Cap
- HDL 1.1B
- OPK 1.1B
- IPO Year
- HDL 2024
- OPK 1995
- Fundamental
- Price
- HDL $17.77
- OPK $1.30
- Analyst Decision
- HDL
- OPK Buy
- Analyst Count
- HDL 0
- OPK 4
- Target Price
- HDL N/A
- OPK $2.28
- AVG Volume (30 Days)
- HDL 1.1K
- OPK 2.3M
- Earning Date
- HDL 11-26-2025
- OPK 10-29-2025
- Dividend Yield
- HDL N/A
- OPK N/A
- EPS Growth
- HDL 197.81
- OPK N/A
- EPS
- HDL 0.09
- OPK N/A
- Revenue
- HDL $805,433,000.00
- OPK $642,067,000.00
- Revenue This Year
- HDL $11.22
- OPK N/A
- Revenue Next Year
- HDL $13.44
- OPK N/A
- P/E Ratio
- HDL $21.28
- OPK N/A
- Revenue Growth
- HDL 9.65
- OPK N/A
- 52 Week Low
- HDL $15.54
- OPK $1.11
- 52 Week High
- HDL $30.00
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- HDL 47.74
- OPK 34.60
- Support Level
- HDL $16.81
- OPK $1.22
- Resistance Level
- HDL $17.87
- OPK $1.36
- Average True Range (ATR)
- HDL 0.22
- OPK 0.07
- MACD
- HDL 0.05
- OPK -0.01
- Stochastic Oscillator
- HDL 70.54
- OPK 28.12
About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. It mission is to become a global integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.